LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo targets tough lung cancer
Disease control OngoingThis study tests adding the immunotherapy drug atezolizumab to standard chemotherapy for people with advanced large-cell neuroendocrine lung cancer, a rare and aggressive type. About 67 participants will receive the combination to see if it helps them live longer and controls the…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated May 26, 2026 06:04 UTC
-
Engineered immune cells take aim at tough lung cancer
Disease control OngoingThis early-phase trial tests a new treatment called LB2102, which uses a patient's own immune cells (T-cells) that are modified in a lab to recognize and attack cancer cells that carry a protein called DLL3. The study includes about 41 adults with advanced small cell lung cancer …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE1 • Sponsor: Legend Biotech USA Inc • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
Radioactive drug targets tough lung cancers in early trial
Disease control OngoingThis early-phase study tests a new radioactive drug (225Ac-ABD147) in people with small cell lung cancer or large cell neuroendocrine carcinoma of the lung that has progressed after platinum-based chemotherapy. The main goals are to check safety, find the best dose, and see initi…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE1 • Sponsor: Abdera Therapeutics Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC